Why Insurance Companies Are Saying No to Generic Drugs

It flies in the face of conventional wisdom: insurance companies that won't pay for a generic medicine, essentially forcing patients to opt for pricey brand-name drugs. 

And yet that's exactly what's happening, report ProPublica and the New York Times. It's "befuddling," says one 41-year-old who says he has to foot a $90 co-pay for Adderall XR because the generic isn't covered by his plan. How'd we get here? 

The report pins it on pharmaceutical companies trying to "squeeze the last profits from products that are facing cheaper generic competition," and asserts they're doing it by shaking hands on back-room deals that may be happening more and more often.

Read the full story on Newser.com

More From Newser

Sponsored Content

Sponsored Content